Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01986673 · ClinicalTrials.gov registry record · Phase 1
Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults
A Phase 1 study, sponsored by Strategic Science & Technologies.
- Completed
- Registry status
- Phase 1
- Development phase
- 62
- Enrollment target
NCT01986673 is a Phase 1 study that has completed, run by Strategic Science & Technologies. The registered enrollment target is 62 participants.
The verdict
NCT01986673, a Phase 1 study, has completed, sponsored by Strategic Science & Technologies.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how a single dose of sildenafil cream (SST-6006) is absorbed and eliminated by the body, with and without the use of a condom, compared to a single oral sildenafil dose and to evaluate the safety of sildenafil cream.
Interventions
- DRUG 5% Sildenafil Cream (SST-6006)
- DRUG Oral Sildenafil 50 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2013-10 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01986673
The ClinicalTrials.gov registry entry for NCT01986673 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Strategic Science & Technologies, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5% Sildenafil Cream (SST-6006) is the first listed.
NCT01986673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01986673 about?
NCT01986673 is a clinical study titled "Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults". The purpose of this study is to evaluate how a single dose of sildenafil cream (SST-6006) is absorbed and eliminated by the body, with and without the use of a condom, compared to a single oral sildenafil dose and to evaluate the safety of sildenafil cream.
What is the current status of trial NCT01986673?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 62 participants. The study started on 2013-10. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01986673?
The interventions under investigation include: 5% Sildenafil Cream (SST-6006) (DRUG), Oral Sildenafil 50 mg (DRUG).
Who is sponsoring clinical trial NCT01986673?
This trial is sponsored by Strategic Science & Technologies, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.